Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.
D061605:Administration, Intravenous; D005260:Female; D006439:Hemodynamics; D006830:Hydralazine; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy / Q000097:blood; D013565:Sympatholytics
D013565:Sympatholytics; D006830:Hydralazine
PREGNANCY TOXEMIAS/blood in; PREGNANCY/blood in; SYMPATHOLYTICS/effects
Am Heart J. 1952 Dec;44(6):910-46
12996442
Am J Obstet Gynecol. 1952 May;63(5):978-88
14923697
J Clin Invest. 1950 Oct;29(10):1367-75
14778900
J Clin Invest. 1948 Jan;27(1):156-63
16695527
J Pharmacol Exp Ther. 1951 Apr;101(4):368-78
14832737
J Pharmacol Exp Ther. 1951 Dec;103(4):368-76
14908854
Circulation. 1952 Jan;5(1):28-37
14896450
J Clin Invest. 1948 Nov;27(6):717-26
16695594
J Clin Invest. 1950 Oct;29(10):1354-66
14778899
Proc Soc Exp Biol Med. 1950 Oct;75(1):23-4
14797721
Circulation. 1951 Feb;3(2):254-9
14812653
AMA Arch Intern Med. 1951 Jul;88(1):1-8
14837538
Proc Soc Exp Biol Med. 1950 Jan;73(1):102
15402536
J Clin Invest. 1952 Oct;31(10):872-9
12990658
Helv Med Acta. 1950 Oct;17(4-5):543-6
14793855
J Clin Invest. 1952 Jan;31(1):72-9
14907883
Experientia. 1950 Jan 15;6(1):19-21
15403090
J Clin Invest. 1950 Sep;29(9):1219-26
14774469
J Am Pharm Assoc Am Pharm Assoc. 1951 Nov;40(11):559-64
14907459
J Clin Invest. 1951 Sep;30(9):916-24
14880619